On ECHEMI
Home > Drugs > China Aoxing Pharmaceutical Company
China Aoxing Pharmaceutical Company
  • Founded in:

    2002-01-20
  • Country:

    China China
  • Address:

    No. 1, Nanhuan East Road, Xinle City, Shijiazhuang, Hebei Province
  • Tax NO.:

    9113010010791788XK
  • Registered Funds:

    70 million yuan
  • Website:

  • Email:

Related Drugs
Huaijiao Pill
Sophora japonica (fried), Sanguisorba officinalis (charcoal), Scutellaria baicalensis, Citrus aurantium (fried), Angelica sinensis, Saposhnikovia divaricata
Name Description Content CAS NO. Registered Holders
SOPHORAE FRUCTUS

Promote blood coagulation and reduce the permeability of blood vessel walls

More

Promote blood coagulation and reduce the permeability of blood vessel walls

0
SANGUISORBAE RADIX CARBONISATUM

It can significantly shorten the coagulation and bleeding time and shrink capillaries

More

It can significantly shorten the coagulation and bleeding time and shrink capillaries

0
RADIX SCUTELLARIAE

This pill uses Sanguisorba officinalis, Sophora japonica flower, Sophora japonica horn and Rhubarb as the main ingredients. Animal experiments have confirmed that Sanguisorba officinalis charcoal decoction can significantly shorten the coagulation and bleeding time, and can constrict capillaries; Sophora japonica flower can maintain the resistance of capillaries, reduce vascular permeability, and restore the normal elasticity of capillaries that have increased fragility and bleeding, and has anti-inflammatory and antispasmodic effects; Sophora japonica horn can promote the rate of blood coagulation and reduce the permeability of blood vessel walls; Rhubarb can constrict blood vessels and shorten blood clotting time.

More

This pill uses Sanguisorba officinalis, Sophora japonica flower, Sophora japonica horn and Rhubarb as the main ingredients. Animal experiments have confirmed that Sanguisorba officinalis charcoal decoction can significantly shorten the coagulation and bleeding time, and can constrict capillaries; Sophora japonica flower can maintain the resistance of capillaries, reduce vascular permeability, and restore the normal elasticity of capillaries that have increased fragility and bleeding, and has anti-inflammatory and antispasmodic effects; Sophora japonica horn can promote the rate of blood coagulation and reduce the permeability of blood vessel walls; Rhubarb can constrict blood vessels and shorten blood clotting time.

0
Citrus aurantium (fried)

This pill uses Sanguisorba officinalis, Sophora japonica flower, Sophora japonica horn and Rhubarb as the main ingredients. Animal experiments have confirmed that Sanguisorba officinalis charcoal decoction can significantly shorten the coagulation and bleeding time, and can constrict capillaries; Sophora japonica flower can maintain the resistance of capillaries, reduce vascular permeability, and restore the normal elasticity of capillaries that have increased fragility and bleeding, and has anti-inflammatory and antispasmodic effects; Sophora japonica horn can promote the rate of blood coagulation and reduce the permeability of blood vessel walls; Rhubarb can constrict blood vessels and shorten blood clotting time.

More

This pill uses Sanguisorba officinalis, Sophora japonica flower, Sophora japonica horn and Rhubarb as the main ingredients. Animal experiments have confirmed that Sanguisorba officinalis charcoal decoction can significantly shorten the coagulation and bleeding time, and can constrict capillaries; Sophora japonica flower can maintain the resistance of capillaries, reduce vascular permeability, and restore the normal elasticity of capillaries that have increased fragility and bleeding, and has anti-inflammatory and antispasmodic effects; Sophora japonica horn can promote the rate of blood coagulation and reduce the permeability of blood vessel walls; Rhubarb can constrict blood vessels and shorten blood clotting time.

0
Angelicae Sinensis Radix

This pill uses Sanguisorba officinalis, Sophora japonica flower, Sophora japonica horn and Rhubarb as the main ingredients. Animal experiments have confirmed that Sanguisorba officinalis charcoal decoction can significantly shorten the coagulation and bleeding time, and can constrict capillaries; Sophora japonica flower can maintain the resistance of capillaries, reduce vascular permeability, and restore the normal elasticity of capillaries that have increased fragility and bleeding, and has anti-inflammatory and antispasmodic effects; Sophora japonica horn can promote the rate of blood coagulation and reduce the permeability of blood vessel walls; Rhubarb can constrict blood vessels and shorten blood clotting time.

More

This pill uses Sanguisorba officinalis, Sophora japonica flower, Sophora japonica horn and Rhubarb as the main ingredients. Animal experiments have confirmed that Sanguisorba officinalis charcoal decoction can significantly shorten the coagulation and bleeding time, and can constrict capillaries; Sophora japonica flower can maintain the resistance of capillaries, reduce vascular permeability, and restore the normal elasticity of capillaries that have increased fragility and bleeding, and has anti-inflammatory and antispasmodic effects; Sophora japonica horn can promote the rate of blood coagulation and reduce the permeability of blood vessel walls; Rhubarb can constrict blood vessels and shorten blood clotting time.

0
SAPOSHNIKOVIAE RADIX

This pill uses Sanguisorba officinalis, Sophora japonica flower, Sophora japonica horn and Rhubarb as the main ingredients. Animal experiments have confirmed that Sanguisorba officinalis charcoal decoction can significantly shorten the coagulation and bleeding time, and can constrict capillaries; Sophora japonica flower can maintain the resistance of capillaries, reduce vascular permeability, and restore the normal elasticity of capillaries that have increased fragility and bleeding, and has anti-inflammatory and antispasmodic effects; Sophora japonica horn can promote the rate of blood coagulation and reduce the permeability of blood vessel walls; Rhubarb can constrict blood vessels and shorten blood clotting time.

More

This pill uses Sanguisorba officinalis, Sophora japonica flower, Sophora japonica horn and Rhubarb as the main ingredients. Animal experiments have confirmed that Sanguisorba officinalis charcoal decoction can significantly shorten the coagulation and bleeding time, and can constrict capillaries; Sophora japonica flower can maintain the resistance of capillaries, reduce vascular permeability, and restore the normal elasticity of capillaries that have increased fragility and bleeding, and has anti-inflammatory and antispasmodic effects; Sophora japonica horn can promote the rate of blood coagulation and reduce the permeability of blood vessel walls; Rhubarb can constrict blood vessels and shorten blood clotting time.

0
Naloxone Hydrochloride Injection
The main component of this product and its chemical name are: 17-allyl-4,5a-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride dihydrate. Its structural formula is: Molecular formula: C19H21NO4HCl2H2O, molecular weight: 399.87.
Name Description Content CAS NO. Registered Holders
Naloxone hydrochloride dihydrate

1. Completely or partially correct the central inhibitory effects of opioids, such as respiratory depression, sedation and hypotension; 2. It has a wake-promoting effect on animals with acute ethanol intoxication; 3. It is a pure opioid receptor antagonist and does not have the excitatory or morphine-like effects of other opioid receptor antagonists; 4. It does not cause respiratory depression, psychotomimetic reactions or miotic reactions; 5. There is no drug tolerance, nor physiological or psychological dependence; 6. It antagonizes the effects of opioids by competing for the same receptor sites.

More

1. Completely or partially correct the central inhibitory effects of opioids, such as respiratory depression, sedation and hypotension; 2. It has a wake-promoting effect on animals with acute ethanol intoxication; 3. It is a pure opioid receptor antagonist and does not have the excitatory or morphine-like effects of other opioid receptor antagonists; 4. It does not cause respiratory depression, psychotomimetic reactions or miotic reactions; 5. There is no drug tolerance, nor physiological or psychological dependence; 6. It antagonizes the effects of opioids by competing for the same receptor sites.

51481-60-8 12
Naloxone Hydrochloride Injection
The main component of this product and its chemical name are: 17-allyl-4,5a-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride dihydrate. Its structural formula is: Molecular formula: C19H21NO4HCl2H2O, molecular weight: 399.87.
Name Description Content CAS NO. Registered Holders
Naloxone hydrochloride dihydrate

1. Completely or partially correct the central inhibitory effects of opioids, such as respiratory depression, sedation and hypotension; 2. It has a wake-promoting effect on animals with acute ethanol intoxication; 3. It is a pure opioid receptor antagonist and does not have the excitatory or morphine-like effects of other opioid receptor antagonists; 4. It does not cause respiratory depression, psychotomimetic reactions or miotic reactions; 5. There is no drug tolerance, nor physiological or psychological dependence; 6. It antagonizes the effects of opioids by competing for the same receptor sites.

More

1. Completely or partially correct the central inhibitory effects of opioids, such as respiratory depression, sedation and hypotension; 2. It has a wake-promoting effect on animals with acute ethanol intoxication; 3. It is a pure opioid receptor antagonist and does not have the excitatory or morphine-like effects of other opioid receptor antagonists; 4. It does not cause respiratory depression, psychotomimetic reactions or miotic reactions; 5. There is no drug tolerance, nor physiological or psychological dependence; 6. It antagonizes the effects of opioids by competing for the same receptor sites.

51481-60-8 12
Naloxone Hydrochloride Injection
The main component of this product and its chemical name are: 17-allyl-4,5a-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride dihydrate. Its structural formula is: Molecular formula: C19H21NO4HCl2H2O, molecular weight: 399.87.
Name Description Content CAS NO. Registered Holders
Naloxone hydrochloride dihydrate

1. Completely or partially correct the central inhibitory effects of opioids, such as respiratory depression, sedation and hypotension; 2. It has a wake-promoting effect on animals with acute ethanol poisoning; 3. It is a pure opioid receptor antagonist and does not have the excitatory or morphine-like effects of other opioid receptor antagonists, and does not cause respiratory depression, psychotomimetic reactions or mydriasis reactions; 4. There is no drug resistance, nor physiological or mental dependence; 5. It antagonizes the effects of opioids by competing for the same receptor sites.

More

1. Completely or partially correct the central inhibitory effects of opioids, such as respiratory depression, sedation and hypotension; 2. It has a wake-promoting effect on animals with acute ethanol poisoning; 3. It is a pure opioid receptor antagonist and does not have the excitatory or morphine-like effects of other opioid receptor antagonists, and does not cause respiratory depression, psychotomimetic reactions or mydriasis reactions; 4. There is no drug resistance, nor physiological or mental dependence; 5. It antagonizes the effects of opioids by competing for the same receptor sites.

51481-60-8 12
Naloxone Hydrochloride Injection
The main component of this product and its chemical name are: 17-allyl-4,5a-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride dihydrate. Its structural formula is: Molecular formula: C19H21NO4HCl2H2O, molecular weight: 399.87.
Name Description Content CAS NO. Registered Holders
Naloxone hydrochloride dihydrate

1. Completely or partially correct the central inhibitory effects of opioids, such as respiratory depression, sedation and hypotension. 2. It has a wake-promoting effect on animals with acute ethanol intoxication. 3. It is a pure opioid receptor antagonist and does not have the excitatory or morphine-like effects of other opioid receptor antagonists; it does not cause respiratory depression, psychotomimetic reactions or miotic reactions. 4. No drug tolerance, nor physiological or psychological dependence, has been observed. 5. Although the mechanism of action is not fully understood, there is sufficient evidence to show that it antagonizes the effects of opioids by competing for the same receptor sites.

More

1. Completely or partially correct the central inhibitory effects of opioids, such as respiratory depression, sedation and hypotension. 2. It has a wake-promoting effect on animals with acute ethanol intoxication. 3. It is a pure opioid receptor antagonist and does not have the excitatory or morphine-like effects of other opioid receptor antagonists; it does not cause respiratory depression, psychotomimetic reactions or miotic reactions. 4. No drug tolerance, nor physiological or psychological dependence, has been observed. 5. Although the mechanism of action is not fully understood, there is sufficient evidence to show that it antagonizes the effects of opioids by competing for the same receptor sites.

51481-60-8 12
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.